Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean P Cleary

Showing results (111-120 of 183) with videos related to

Pageof 19
Sort By:
Hepatology (Baltimore, Md.)|February 18, 2022
Dynamic risk profiling of HCC recurrence after curative intent liver resectionTommy Ivanics, Carla Fiorella Murillo Perez, Marco P A W Claasen, et al.
Annals of Surgical Oncology|April 30, 2024
Value of Surgical Cytoreduction in Patients with Small Intestinal Neuroendocrine Tumors Metastatic to the Liver and PeritoneumHallbera Gudmundsdottir, Alessandro Fogliati, Travis E Grotz, et al.
Journal of the American College of Surgeons|April 7, 2023
Yield of Staging Laparoscopy for Pancreatic Cancer in the Modern Era: Analysis of More than 1,000 Consecutive PatientsHallbera Gudmundsdottir, Jennifer A Yonkus, Roberto Alva-Ruiz, et al.
Annals of Surgical Oncology|May 19, 2023
Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver Metastases: Long-Term Follow-up Evaluation of More Than 500 PatientsHallbera Gudmundsdottir, Elizabeth B Habermann, Robert A Vierkant, et al.
Annals of Surgical Oncology|February 6, 2024
Outcomes of Neoadjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Neoplasm Compared with de Novo Pancreatic AdenocarcinomaAlessandro Fogliati, Andrea Zironda, Guido Fiorentini, et al.
Annals of Surgical Oncology|June 22, 2022
Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine TumorsHallbera Gudmundsdottir, Ron Pery, Rondell P Graham, et al.
Cancers|December 17, 2024
Effectiveness and Safety of Irreversible Electroporation When Used for the Ablation of Stage 3 Pancreatic Adenocarcinoma: Initial Results from the DIRECT Registry StudyRobert C G Martin, Rebekah Ruth White, Malcolm M Bilimoria, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 25, 2023
Minimally invasive vs. open approach to the simultaneous treatment of colorectal tumors with synchronous liver metastasis: a single center, propensity-score matched analysis from Mayo clinicGuido Fiorentini, Andrea Zironda, Giacomo Calini, et al.
Cancer Medicine|July 21, 2021
Perception versus reality: A National Cohort Analysis of the surgery-first approach for resectable pancreatic cancerJohn R Bergquist, Cornelius A Thiels, Christopher R Shubert, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 26, 2022
Outcomes of pancreatectomy with portomesenteric venous resection and reconstruction for locally advanced pancreatic neuroendocrine neoplasmsHallbera Gudmundsdottir, Jennifer L Tomlinson, Rondell P Graham, et al.
Pageof 19

Showing results (111-120 of 183) with videos related to

Sort By:
Pageof 19
Hepatology (Baltimore, Md.)|February 18, 2022
Dynamic risk profiling of HCC recurrence after curative intent liver resectionTommy Ivanics, Carla Fiorella Murillo Perez, Marco P A W Claasen, et al.
Annals of Surgical Oncology|April 30, 2024
Value of Surgical Cytoreduction in Patients with Small Intestinal Neuroendocrine Tumors Metastatic to the Liver and PeritoneumHallbera Gudmundsdottir, Alessandro Fogliati, Travis E Grotz, et al.
Journal of the American College of Surgeons|April 7, 2023
Yield of Staging Laparoscopy for Pancreatic Cancer in the Modern Era: Analysis of More than 1,000 Consecutive PatientsHallbera Gudmundsdottir, Jennifer A Yonkus, Roberto Alva-Ruiz, et al.
Annals of Surgical Oncology|May 19, 2023
Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver Metastases: Long-Term Follow-up Evaluation of More Than 500 PatientsHallbera Gudmundsdottir, Elizabeth B Habermann, Robert A Vierkant, et al.
Annals of Surgical Oncology|February 6, 2024
Outcomes of Neoadjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Neoplasm Compared with de Novo Pancreatic AdenocarcinomaAlessandro Fogliati, Andrea Zironda, Guido Fiorentini, et al.
Annals of Surgical Oncology|June 22, 2022
Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine TumorsHallbera Gudmundsdottir, Ron Pery, Rondell P Graham, et al.
Cancers|December 17, 2024
Effectiveness and Safety of Irreversible Electroporation When Used for the Ablation of Stage 3 Pancreatic Adenocarcinoma: Initial Results from the DIRECT Registry StudyRobert C G Martin, Rebekah Ruth White, Malcolm M Bilimoria, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 25, 2023
Minimally invasive vs. open approach to the simultaneous treatment of colorectal tumors with synchronous liver metastasis: a single center, propensity-score matched analysis from Mayo clinicGuido Fiorentini, Andrea Zironda, Giacomo Calini, et al.
Cancer Medicine|July 21, 2021
Perception versus reality: A National Cohort Analysis of the surgery-first approach for resectable pancreatic cancerJohn R Bergquist, Cornelius A Thiels, Christopher R Shubert, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 26, 2022
Outcomes of pancreatectomy with portomesenteric venous resection and reconstruction for locally advanced pancreatic neuroendocrine neoplasmsHallbera Gudmundsdottir, Jennifer L Tomlinson, Rondell P Graham, et al.
Pageof 19